Lista de obras -

A clinical study of lupron depot in the treatment of women with Alzheimer's disease: preservation of cognitive function in patients taking an acetylcholinesterase inhibitor and treated with high dose lupron over 48 weeks

artículo científico publicado en 2015

Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease

artículo científico publicado en 2003

Amyloid-beta, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs?

artículo científico publicado en 2002

Amyloid-beta-induced toxicity of primary neurons is dependent upon differentiation-associated increases in tau and cyclin-dependent kinase 5 expression.

artículo científico publicado en 2004

Amyloid-beta: a (life) preserver for the brain

artículo científico publicado en 2002

Amyloid-beta: a vascular sealant that protects against hemorrhage?

artículo científico publicado en 2002

Antibodies to potato virus Y bind the amyloid beta peptide: immunohistochemical and NMR studies

artículo científico publicado en 2008

Apoptotic and Oxidative Indicators in Alzheimer's Disease

scholarly article

Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

scientific article published on 01 September 2019

Beyond estrogen: targeting gonadotropin hormones in the treatment of Alzheimer's disease

artículo científico publicado en 2004

Call for Elan to publish Alzheimer's trial details.

artículo científico publicado en 2002

Cerebral hemorrhage and amyloid-beta

artículo científico publicado en 2003

Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease

artículo científico publicado en 2009

Conjugated Linoleic Acid Administration Induces Amnesia in Male Sprague Dawley Rats and Exacerbates Recovery from Functional Deficits Induced by a Controlled Cortical Impact Injury

artículo científico publicado en 2017

Copper Induces Apoptosis of Neuroblastoma Cells Via Post-translational Regulation of the Expression of Bcl-2-family Proteins and the tx Mouse is a Better Model of Hepatic than Brain Cu Toxicity

artículo científico publicado en 2008

Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta

artículo científico publicado en 2004

Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease

artículo científico publicado en 2004

Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology

artículo científico publicado en 2002

Estrogen bows to a new master: the role of gonadotropins in Alzheimer pathogenesis

artículo científico publicado en 2005

Gender differences in Alzheimer disease: the role of luteinizing hormone in disease pathogenesis

artículo científico publicado en 2005

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

artículo científico publicado en 2019

Gonadotropins: a cohesive gender-based etiology of Alzheimer disease

artículo científico publicado en 2006

Ill-fated amyloid-beta vaccine

artículo científico publicado en 2002

Increased expression of the remodeling- and tumorigenic-associated factor osteopontin in pyramidal neurons of the Alzheimer's disease brain

artículo científico publicado en 2007

Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults

artículo científico publicado en 2016

Involvement of Maillard reactions in Alzheimer disease

artículo científico publicado en 2002

Iron homeostasis is maintained in the brain, but not the liver, following mild hypoxia

artículo científico publicado en 2007

Iron: a pathological mediator of Alzheimer disease?

artículo científico publicado en 2002

Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases?

artículo científico publicado en 2002

Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice

artículo científico publicado en 2006

Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition

artículo científico publicado en 2004

Menopause, estrogen, and gonadotropins in Alzheimer's disease

scientific article published on January 2008

Metal Homeostasis and Its Relation to Oxidative Stress in Alzheimer’s Disease

Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence

artículo científico publicado en 2003

Mid-life dementia risk scores as a predictor of CSF biomarker response to simvastatin therapy in asymptomatic adults at risk for Alzheimer's disease: The ESPRIT study

artículo científico publicado en 2010

Neuroprotective properties of Bcl-w in Alzheimer disease

artículo científico publicado en 2004

O2-04-07 Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1 associated regulator of cyclin B, in Alzheimer disease

Oxidative Damage and Antioxidant Responses in Alzheimer's Disease

article

Predicting the failure of amyloid-beta vaccine.

artículo científico publicado en 2002

Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

artículo científico publicado en 2017

Reduction of inclusion body pathology in ApoE-deficient mice fed a combination of antioxidants

artículo científico publicado en 2003

Relationship between CSF biomarkers and language fluency in asymptomatic middle-aged adults at increased risk for Alzheimer's disease: The ESPRIT study

artículo científico publicado en 2010

Senile plaque composition and posttranslational modification of amyloid-beta peptide and associated proteins

artículo científico publicado en 2002

Steroidogenic acute regulatory protein (StAR): evidence of gonadotropin-induced steroidogenesis in Alzheimer disease

artículo científico publicado en 2006

Targeting gonadotropins: an alternative option for Alzheimer disease treatment

artículo científico publicado en 2006

The Influence of Metabolic Syndrome on Simvastatin Therapy In Asymptomatic Adults at Risk for Alzheimer's Disease: The ESPRIT Study

artículo científico publicado en 2010

The cell cycle and hormonal fluxes in Alzheimer disease: a novel therapeutic target

artículo científico publicado en 2006

The estrogen myth: potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's disease

artículo científico publicado en 2006

The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications

artículo científico publicado en 2002

The state versus amyloid-beta: the trial of the most wanted criminal in Alzheimer disease

artículo científico publicado en 2002

Lista de obras de

A clinical study of lupron depot in the treatment of women with Alzheimer's disease: preservation of cognitive function in patients taking an acetylcholinesterase inhibitor and treated with high dose lupron over 48 weeks

Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease

Amyloid-beta, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs?

Amyloid-beta-induced toxicity of primary neurons is dependent upon differentiation-associated increases in tau and cyclin-dependent kinase 5 expression.

Amyloid-beta: a (life) preserver for the brain

Amyloid-beta: a vascular sealant that protects against hemorrhage?

Antibodies to potato virus Y bind the amyloid beta peptide: immunohistochemical and NMR studies

Apoptotic and Oxidative Indicators in Alzheimer's Disease

Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Beyond estrogen: targeting gonadotropin hormones in the treatment of Alzheimer's disease

Call for Elan to publish Alzheimer's trial details.

Cerebral hemorrhage and amyloid-beta

Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease

Conjugated Linoleic Acid Administration Induces Amnesia in Male Sprague Dawley Rats and Exacerbates Recovery from Functional Deficits Induced by a Controlled Cortical Impact Injury

Copper Induces Apoptosis of Neuroblastoma Cells Via Post-translational Regulation of the Expression of Bcl-2-family Proteins and the tx Mouse is a Better Model of Hepatic than Brain Cu Toxicity

Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta

Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease

Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology

Estrogen bows to a new master: the role of gonadotropins in Alzheimer pathogenesis

Gender differences in Alzheimer disease: the role of luteinizing hormone in disease pathogenesis

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Gonadotropins: a cohesive gender-based etiology of Alzheimer disease

Ill-fated amyloid-beta vaccine

Increased expression of the remodeling- and tumorigenic-associated factor osteopontin in pyramidal neurons of the Alzheimer's disease brain

Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults

Involvement of Maillard reactions in Alzheimer disease

Iron homeostasis is maintained in the brain, but not the liver, following mild hypoxia

Iron: a pathological mediator of Alzheimer disease?

Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases?

Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice

Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition

Menopause, estrogen, and gonadotropins in Alzheimer's disease

Metal Homeostasis and Its Relation to Oxidative Stress in Alzheimer’s Disease

Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence

Mid-life dementia risk scores as a predictor of CSF biomarker response to simvastatin therapy in asymptomatic adults at risk for Alzheimer's disease: The ESPRIT study

Neuroprotective properties of Bcl-w in Alzheimer disease

O2-04-07 Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1 associated regulator of cyclin B, in Alzheimer disease

Oxidative Damage and Antioxidant Responses in Alzheimer's Disease

Predicting the failure of amyloid-beta vaccine.

Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

Reduction of inclusion body pathology in ApoE-deficient mice fed a combination of antioxidants

Relationship between CSF biomarkers and language fluency in asymptomatic middle-aged adults at increased risk for Alzheimer's disease: The ESPRIT study

Senile plaque composition and posttranslational modification of amyloid-beta peptide and associated proteins

Steroidogenic acute regulatory protein (StAR): evidence of gonadotropin-induced steroidogenesis in Alzheimer disease

Targeting gonadotropins: an alternative option for Alzheimer disease treatment

The Influence of Metabolic Syndrome on Simvastatin Therapy In Asymptomatic Adults at Risk for Alzheimer's Disease: The ESPRIT Study

The cell cycle and hormonal fluxes in Alzheimer disease: a novel therapeutic target

The estrogen myth: potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's disease

The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications

The state versus amyloid-beta: the trial of the most wanted criminal in Alzheimer disease